Document:

<PAGE>

                                                                    EXHIBIT 10.7

PRIVATE & CONFIDENTIAL

                           THE TRANSGENOMIC INC. 1997
                                STOCK OPTION PLAN

                            (AS AMENDED AND RESTATED)

                     UK APPROVED STOCK OPTION SUB PLAN 1999

                APPROVED BY THE INLAND REVENUE UNDER REF: X19932

                                DELOITTE & TOUCHE
                                   HILL HOUSE
                              1, LITTLE NEW STREET
                                     LONDON
                                    EC4A 3TR

                                  Ref:- SVW/NN

<PAGE>

                              THE TRANSGENOMIC INC.
                             1997 STOCK OPTION PLAN

                     UK APPROVED STOCK OPTION SUB PLAN 1999

1.   INTRODUCTION

1.1  For the purpose of granting options under a scheme approved by the United
     Kingdom's Inland Revenue under Schedule 9 to the United Kingdom's Income
     and Corporation Taxes Act 1988 ("Schedule 9"), the terms of the
     Transgenomic Inc. Amended and Restated 1997 Stock Option Plan, as amended
     and restated as of 14 October 1997 (hereafter called the "1997 Plan") are
     amended by the creation of the UK Share Option Sub-Plan 1999 ("the
     Sub-Plan") which shall be applicable to the employees of Transgenomic Inc.
     and its subsidiaries and affiliates who are resident in the United Kingdom.

1.2  The terms of the Sub Plan shall be the terms of the 1997 Plan, amended as
     set out below.

2.   NATURE OF OPTIONS

2.1  No options or rights may be granted under the Sub Plan other than Approved
     Stock Options.

2.2  The Company Stock over which Approved Stock Options are granted under the
     Sub Plan must satisfy paragraphs 10-14 of Schedule 9.

3.   ELIGIBILITY AND GRANT OF OPTIONS

3.1  No Approved Stock Options may be granted under the Sub Plan to a person who
     is not an employee or a full-time director of the Company or such companies
     under the control of the Company as may be nominated from time to time
     within the meaning of paragraph 27 of Schedule 9.

3.2  For the purposes of Rule 3.1 of this Sub Plan above, a person shall be
     treated as a full-time director of a Company if he is obliged to devote to
     the performance of the duties of his office of employment with the Company,
     or with the Company and any other participating Company, not less than 25
     hours a week (excluding meal-breaks).

3.3  No Approved Stock Options may be granted under the Sub Plan to, or
     exercised by, a person who is not eligible to participate by virtue of
     paragraph 8 of Schedule 9.

3.4. No person shall be granted an option under the Sub Plan for which the
     exercise price, when added to the exercise price of all Approved Stock
     Options for such individual subsisting under the Sub Plan, or any other
     option granted under a discretionary share option scheme approved by the
     United Kingdom Inland Revenue and established by the Company or any
     associated company (as defined in section 187(2) of the Income and
     Corporation Taxes Act 1988), would exceed L30,000 (or such limit as may
     from time to time be provided for by paragraph 28 of Schedule 9).

<PAGE>

3.5  No option shall be granted under this Sub Plan at any price which is less
     than its Fair Market Value, or in the case of an option to subscribe for
     shares, the nominal value of the Company Stock, if higher.

3.6  If and so long as the Company Stock is listed on the London Stock Exchange
     or the New York Stock Exchange, "Fair Market Value" shall mean its middle
     market quotation (as derived from the Daily Official List). If and so long
     as the Company Stock is not so listed, "Fair Market Value" shall mean the
     fair market value of the relevant stock on the relevant date, as determined
     in accordance with Part VIII of the Taxation of Chargeable Gains Act 1992
     and agreed in advance of each grant with the Shares Valuation Division of
     the UK Inland Revenue.

3.7  The Committee may grant an Approved Stock Option subject to such objective
     conditions as it may determine and specify at the date of grant, provided
     that such conditions have been approved by the UK Inland Revenue.

3.8  Section 6.3 of the 1997 Plan shall not apply.

3.9  Section 7.2 of the 1997 Plan shall read as if it contained only the words:

     "Payment in full for the number of shares purchased under any Approved
     Stock Option shall be made to the Company in cash at the time of such
     exercise".

3.10 The Committee shall procure the issue or transfer of shares pursuant to the
     exercise of an Approved Stock Option within 28 days following the effective
     date of exercise of the Option. Shares to be issued pursuant to the Sub
     Plan shall rank pari passu in all respects with the Company Stock of the
     same class for the time being in issue same as regards any rights attaching
     to a record date prior to the date of issue and in the case of a transfer
     of shares, the transferee shall not acquire any rights attaching to such
     shares by reference to a record date prior to the date of transfer.

4.   ADJUSTMENTS

4.1  Article VIII of the 1997 Plan shall read as if it contained only the words:

     "The number of shares of Company Stock over which an Approved Stock Option
     is granted and the exercise price shall be adjusted in such manner as the
     Committee shall determine following any capitalisation issue, rights issue,
     subdivision, consolidation or reduction of share capital of the Company or
     any other variation of share capital to the intent that (as nearly as may
     be without involving fractions of a share or an exercise price calculated
     to more than two places of decimals) the exercise price payable in respect
     of an Approved Stock Option shall remain unchanged provided that:-

     (a) the aggregate amount payable on the exercise of the Approved Stock
         Option in full is not increased;

     (b) the exercise price for shares of Company Stock is not reduced below its
         nominal value; and

<PAGE>

     (c) no such adjustment is made without the prior approval of the UK Inland
         Revenue.

5.   EFFECT OF CORPORATE CHANGES

5.1  If any person obtains Control (as defined in Rule 5.6 below) of the Company
     as a result of making:

     (a) a general offer to acquire the whole of the issued stock of the Company
        (where such an offer is made upon a condition such that if it is
         satisfied the person making the offer will have control of the
         Company; or

     (b) a general offer to acquire all the shares in the Company which are of
         the same class as the Company Stock subject to Approved Stock Options;

     any existing Approved Stock Option may be exercised within 6 months of the
     time when the person making such an offer obtains Control of the Company.

5.2  If, as a result of the events specified in 5.1 another Company has obtained
     Control of the Company, a holder of an Approved Stock Option may, by
     agreement with that other Company (the "Acquiring Company"), within 6
     months release such existing options held over the Company Stock (the "Old
     Option") for an option fulfilling the requirements of Rule 5.3 (a "New
     Option").

5.3  An Approved Stock Option shall only be New Option if it:

     (a) is held over stock in the Acquiring Company or some other Company
         falling within Schedule 9 paragraph 10(b) or (c);

     (b) is a right to acquire such an amount of stock as would have on
         acquisition of the New Option an aggregate market value equal to the
         aggregate market value of the stock which was subject to the Old
         Option upon its release;

     (c) has a subscription price such that the aggregate price payable upon the
         complete exercise equals the aggregate price which would have been
         payable on completion of the Old Option; and

     (d) is otherwise identical to the Old Option.

5.4  The New Option shall, for all other purposes of this Sub Plan, be treated
     as having been acquired at the same time as Old Option.

5.5  Where New Options are granted under this Rule, all references to
     Transgenomic Inc in the 1997 Plan, or this Sub Plan, shall be construed as
     references to the Acquiring Company, or as the case may be, to any other
     company to which the Stock or stock subject to New Options relates.

5.6  For the purposes of this Rule, a person shall be deemed to have Control of
     the Company, if he and others acting in concert with him have obtained
     control of it, within the meaning of section 840 of the UK Income and
     Corporation Taxes Act 1988

<PAGE>

6.   TERMINATION OF OPTIONS

6.1  For the purposes of this Sub Plan, Section 10 of the 1997 Plan shall be
     read as if it contained only the words:

     "An Approved Stock Option may be exercised by the personal representative
     of a deceased Optionee within one year following the date of his death and
     by the Optionee within one year following the date upon which such Optionee
     ceases to hold office or employment with the Company, if such cessation is
     as a result of:

     (a)  permanent or total disability (provided the Optionee has been
          continuously employed by the Company for at least three years or such
          shorter period as the Committee may determine upon the grant of any
          Approved Stock Option);

     (b)  pregnancy;

     (c)  redundancy within the meaning of the UK Employment Rights Act 1996;

     (d)  retirement at the normal age provided that the option has been held
          for at least 2 years at the date of such retirement (or such longer
          period as the Committee may determine upon the grant of any Approved
          Stock Option); or

     (e)  any other reason at the discretion of the Committee.

6.2  Where an Optionee ceases to hold office or employment with the Company for
     any reason other than those set out in Rule 6.1, the Approved Stock Option
     shall lapse, whether or not vested.

7.   MISCELLANEOUS

7.1  Section 11.2 shall not apply to the Sub Plan.

7.2  In the event of any conflict between the terms of the 1997 Plan and this
     Sub Plan, the Sub Plan shall prevail.

7.3  No amendment made to:

     (a)  any Approved Stock Option granted under this Sub Plan;

     (b)  any part of this Sub Plan;

     (c)  any part of the 1997 Plan insofar as those amendments affect this Sub
          Plan,

     shall have any effect until it has been approved by the Board of the UK
     Inland Revenue.<PAGE>

                                                                    EXHIBIT 10.8

                              EMPLOYMENT AGREEMENT

         THIS AGREEMENT is made as of March 1, 2000, by and between
Transgenomic, Inc., a Delaware corporation (the "Company"), and Collin D'Silva
("Employee").

         The Company and Employee desire to enter into an Employment Agreement
(this "Agreement"). Accordingly, the Company and Employee agree as follows:

         Section 1. EFFECTIVE DATE; POSITION; TERM. This Agreement shall become
effective on March 1, 2000 (the "Effective Date"). The Company shall employ
Employee as Chief Executive Officer. The initial term of the Agreement will be
for a minimum of four (4) years from the Effective Date, and the Agreement may
be extended upon mutual consent of the parties.

         Section 2.  POSITION AND DUTIES.  During the Employment Period:

                  (a) Employee shall have the normal responsibilities, duties
         and authorities of Chief Executive Officer.

                  (b) Employee shall report to the Board of Directors of the
         Company and Employee shall perform faithfully the executive duties
         assigned to him to the best of his ability in a diligent, trustworthy,
         businesslike and efficient manner and will devote his full business
         time and attention to the business and affairs of the Company and its
         Subsidiaries and Affiliates; provided, however, that Employee may serve
         as a director of or a consultant to other corporations which do not
         compete with the Company, nonprofit corporations, civic organizations,
         professional groups and similar entities.

                  (c) For purposes of this Agreement, "Subsidiary" shall mean
         any corporation or other entity of which securities having a majority
         of the voting power in electing directors or comparable management are,
         at the time of determination, owned by the Company, directly or through
         one or more Subsidiaries.

                  (d) For purposes of this Agreement, "Affiliate" of any
         particular person means any other person controlling, controlled by or
         under common control with such particular person.

<PAGE>

         Section 3.  BASIC COMPENSATION.

                  (a) BASE SALARY. As compensation for his services hereunder,
the Company shall pay to Employee during the Employment Period an initial base
salary of $132,000.00 per year.

         Base Salary shall be payable in equal installments in arrears on a
biweekly basis or as otherwise may be mutually agreed upon.

         The salary will be reviewed and determined by the Compensation
Committee of the Board of Directors.

         Section 4. BONUS. In addition to the Base Salary, Employee shall be
eligible to receive an annual bonus based on Employee's performance in
conjunction with specific mutually agreed goals and objectives defined prior to
such calendar year payable at such time or times during or following each
calendar year as shall be determined by the Chief Executive Officer and the
Board of Directors (the "Board") or a committee thereof in its sole discretion
and based on formulas to be determined each year by the Board or such committee
in its sole discretion for the Company's management bonus plan.

         Section 5. PARTICIPATION IN EMPLOYEE BENEFIT PLANS. Employee will be
entitled to participate in all Company salaried employee benefit plans and
programs, subject to the terms and conditions of each such employee benefit plan
or program and to the extent commensurate with his position as Chief Executive
Officer.

         Section 6.  OTHER BENEFITS.

                  (a) VACATION. Employee shall initially be entitled to four
         weeks' paid vacation each year.

                  (b) INSURANCE. The Company shall make available to Employee
         health, hospitalization, major medical insurance and dental insurance
         (including dependent coverage), and other benefits from time to time
         provided to employees.

         Section 7. BUSINESS EXPENSES. The Company shall reimburse Employee for
all reasonable expenses incurred by him in the course of performing his duties
under this Agreement which are consistent with the Company's policies in effect
from time to time with respect to travel, entertainment and other business
expenses, subject to the Company's requirements with respect to report and
documentation of such expenses.

         Section 8.  TERMINATION OF EMPLOYMENT.

                  (a) EVENTS OF TERMINATION AND SEVERANCE PAYMENT. In the event
         that,

2
<PAGE>

         during the term of this Agreement, Employee is discharged for any
         reason other than for Just Cause (as defined below), Employee shall be
         entitled to receive certain payment (the "Severance Payment") following
         termination of employment. Severance Payment will be made at the
         Employees then current base salary for an amount equal to 12 (twelve)
         months' salary.

                  (b) "Just Cause" means embezzlement or misappropriation of
         corporate funds, other acts of dishonesty, significant activities
         materially harmful to the reputation of the Company as reasonably
         defined by the Company, commission of a felony, willful refusal to
         perform or substantial disregard of the duties properly assigned,
         significant violation of any statutory or common law, duty of loyalty
         to the Company or a material violation of Section 10 or 11 below, or
         takes any other action materially detrimental to the best interest of
         the Company as reasonably determined by the Company.

                  (c) EFFECT OF BREACH OF NONCOMPETITION PROVISIONS. In the
         event Employee breaches or otherwise fails to comply with the
         provisions of Section 10 or 11 below, then, in addition to any other
         remedies provided herein or at law or in equity, the Company shall have
         the right to require return of any severance payment made to the
         Employee. Return of such Severance Payment pursuant to the preceding
         sentence shall not relieve Employee's obligations pursuant to Section
         10 or 11 below.

         Section 9. ASSIGNMENT AND SUCCESSION. (a) The rights and obligations of
the Company under this Agreement shall inure to the benefit of and be binding
upon its respective successors and assigns, and Employee's rights and
obligations hereunder shall inure to the benefit of and be binding upon his
successors and permitted assigns, whether so expressed or not.

                  (b) Employee acknowledges that the services to be rendered by
         him hereunder are unique and personal. Accordingly, Employee may not
         pledge or assign any of his rights or delegate any of his duties or
         obligations under this Agreement without the express prior written
         consent of the Company.

                  (c) The Company may not assign its interest in or obligations
         under this Agreement without the prior written consent of Employee.

         Section 10. CONFIDENTIAL INFORMATION. (a) Employee acknowledges that
the information, observations and data obtained by him during the course of his
performance under this Agreement concerning the business or affairs of the
Company and its Subsidiaries is the property of the Company or such Subsidiary,
as the case may be. Therefore, during the Employment Period and at all times
thereafter, Employee will not directly or indirectly use, divulge, furnish or
make accessible to any unauthorized person or use for his own account any
confidential or proprietary information or trade secrets of the Company or any
of its

3
<PAGE>

Subsidiaries without the Board's prior written consent except and to the extent
required by law (and upon prompt written notice of such requirement to the
Company and such Subsidiary) any of such information, observations or data
without the Board's prior written consent unless and to the extent that the
aforementioned matters become generally known to and available for use by the
public other than as a result of Employee's acts or omissions to act. In the
event Employee shall be required by law to make any disclosure as set forth
above, Employee shall promptly notify the Company and such Subsidiary in writing
of the basis for and the extent of the required disclosure and shall cooperate
with the Company and such Subsidiary to preserve in full the confidentiality of
all intellectual property, trade secrets, confidential information and other
proprietary rights of the Company and such Subsidiary. For purposes hereof,
confidential information does not include any information that has become
publicly known are made generally available through no wrongful act of Employee
or of any other person who is subject to a confidentiality agreement with the
Company.

                 (b) Employee agrees to deliver to the Company at the
         termination of his employment, or at any other time upon written
         request by the Company, all memoranda, notes, plans, records, reports
         and other documents relating to the business of the Company and its
         Subsidiaries which he may then possess or have under his control.

         Section 11. COVENANT NOT TO COMPETE. (a) Employee agrees that during
the Employment Period, and for one year after the Termination Date (the
"Noncompete Period"), he will neither directly nor indirectly engage in, have
any interest in, own, manage, operate, control, be connected with as a
stockholder, joint venturer, officer, employee, partner or consultant or invest
or participate in a business competing with any of the businesses then conducted
(or, to the knowledge of Employee, planned to be conducted within one year) by
the Company or any of its successors or then Subsidiaries, within any
geographical area in which the Company or its Subsidiaries engage or plan within
one year to engage in any such businesses. During the Noncompete Period,
Employee shall not directly or indirectly through another entity (i) induce or
attempt to induce any employee of the Company or any Subsidiary to leave the
employ of the Company or such Subsidiary, or in any way interfere with the
relationship between the Company or any Subsidiary and any employee thereof,
(ii) hire any person who was an employee of the Company or any Subsidiary at any
time during the Employment Period or (iii) induce or attempt to induce any
customer, supplier, licensee or other business relation of the Company or any
Subsidiary to cease doing business with the Company or such Subsidiary, or in
any way interfere with the relationship between any such customer, supplier,
licensee or business relation and the Company or any Subsidiary.

                  (b) Nothing contained in this Section 11 shall prevent
         Employee from owning up to a 5% interest in any corporation or entity
         having one or more classes of its securities listed on a national
         securities exchange or publicly traded in the over-the-counter market,
         provided Employee is not actively involved in the operation or
         management of such corporation or entity. Nothing contained herein
         shall prevent Employee from serving as a paid consultant to other
         companies or serving as a

4
<PAGE>

         member of the Board of Directors of other corporations.

                  (c) If, under the circumstances existing at the time of
         enforcement of this Section 11, the period, scope or geographic area
         described in this Section 12 shall be found or held to be unreasonable,
         the parties hereto agree that the maximum period, scope or geographic
         area reasonable under the circumstances shall be substituted for the
         stated period, scope or geographic area.

         Section 12. CONFLICTS OF INTEREST POLICIES. Employee shall diligently
adhere to the Company's Conflict of Interest Policy as adopted by the Board and
in effect from time to time.

         Section 13. ARBITRATION AND EQUITABLE REMEDIES. (a) Except as provide
in Section 13(b) hereof, the parties agree that any dispute or controversy
arising out of, relating to, or concerning the interpretation, construction,
performance or breach of this Agreement, shall be settled by arbitration to be
held in Nebraska, in accordance with the Employment Dispute Resolution rules of
the American Arbitration Association then in effect. The arbitrator may grant
injunctions or other relief in such dispute or controversy and the decision of
the arbitrator shall be final, conclusive and binding on the parties to the
arbitration. Judgment may be entered on the arbitrator's decision in any court
having jurisdiction. The Company and Employee shall each pay one-half of the
costs and expenses of such arbitration, and each shall separately pay the fees
and expenses of their respective legal counsel.

         THIS ARBITRATION CLAUSE CONSTITUTES A WAIVER OF EMPLOYEE'S RIGHT TO A
JURY TRIAL AND RELATES TO THE RESOLUTION OF ALL DISPUTES RELATING TO ALL ASPECTS
OF THE EMPLOYER/EMPLOYEE RELATIONSHIP.

                  (b) Notwithstanding paragraph (a) of this Section 13, the
         parties agree that, in the event of the breach or threatened breach of
         Sections 10, 11 or 12 of this Agreement by Employee, monetary damages
         alone would not be an adequate remedy to the Company and its
         Subsidiaries for the injury that would result from such breach, and
         that the Company and its Subsidiaries shall be entitled to apply to any
         court of competent jurisdiction for specific performance and/or
         injunctive relief (without posting bond or other security) in order to
         enforce or prevent any violation of such provisions of this Agreement.
         Employee further agrees that any such injunctive relief obtained by the
         Company or any of its Subsidiaries shall be in addition to monetary
         damages.

         Section 14. INDEMNIFICATION. The Company agrees to indemnify and hold
harmless Employee for any and all actions taken by Employee in carrying out his
duties under this Agreement.

         Section 15 ENTIRE AGREEMENT. This Agreement represents the entire
agreement

5
<PAGE>

between the parties relating to the subject matters covered hereby and shall
supersede any prior understandings, agreements or representations by or between
the parties, written or oral, which may have related to the subject matter
hereof in any way and shall not be amended or waived except in a writing signed
by the parties hereto.

         Section 16. NOTICES. Any notice or request required or permitted to be
given hereunder shall be in writing and will be deemed to have been given (i)
when delivered personally, sent by telecopy (with hard copy to follow) or
overnight express courier or (ii) five days following mailing by certified or
registered mail, postage prepaid and return receipt requested, to the addresses
below unless another address is specified by such party in writing:
<TABLE>

        <S>                       <C>
        To the Company:           Transgenomic, Inc.
                                  5600 South 42nd Street
                                  Omaha, NE  68107
                                  Telephone:  (402) 738-5480
                                  Telecopy:   (402) 733-1264

        To the Employee:          Collin D'Silva
                                  5600 South 42nd Street
                                  Omaha, NE  68107
                                  Telephone: (402)  738-5480
                                  Telecopy:  (402) 733-1264
</TABLE>

         Section 17. HEADINGS. The article and section headings herein are for
convenience of reference only and shall not define or limit the provisions
hereof.

         Section 18. APPLICABLE LAW. The corporate law of the State of Delaware
will govern all questions concerning the relative rights of the Company and its
stockholders. All other questions concerning the construction, validity and
interpretation of this Agreement shall be governed by the internal laws of the
State of Nebraska.

         Section 19. SEVERABILITY. Whenever possible, each provision of this
Agreement will be interpreted in such manner as to be effective and valid under
applicable law, but if any provision of this Agreement is held prohibited by,
invalid or unenforceable in any respect under applicable law, such provision
will be ineffective only to the extent of such prohibition or invalidity,
without invalidating the remainder of such provision or the remaining provisions
of this Agreement.

         Section 20. AMENDMENTS AND WAIVERS. Any provision of this Agreement may
be amended or waived only with the prior written consent of the Company and
Employee.

         Section 21. NO STRICT CONSTRUCTION. The language used in this Agreement
will be

6
<PAGE>

deemed to be the language chosen by the parties hereto to express their mutual
intent, and no rule of strict construction will be applied against any party
hereto.

         Section 22. COUNTERPARTS. This Agreement may be executed in separate
counterparts, each of which is deemed to be an original and all of which taken
together constitute one and the same agreement.

         Section 23. EMPLOYEE REPRESENTATIONS. Employee hereby represents and
warrants to the Company that (i) the execution, delivery and performance of this
Agreement by Employee does not and will not conflict with, breach, violate or
cause a default under any contract, agreement, instrument, order, judgment or
decree to which Employee is a party or by which he is bound, (ii) Employee is
not a party to or bound by any employment agreement, noncompete agreement or
confidentiality agreement with any other person or entity and (iii) upon the
execution and delivery of this Agreement by the Company, this Agreement shall be
the valid and binding obligation of Employee, enforceable in accordance with its
terms.

         Section 24. SURVIVAL. Sections 10, 11 and 14 shall survive and continue
in full force in accordance with their terms notwithstanding any termination of
the Employment Period.

         IN WITNESS WHEREOF, the Company has caused this Agreement to be signed
by its duly authorized officer and Employee has signed this Agreement as of the
date first written above.

                               TRANSGENOMIC, INC.

                               By /s/Stephen F. Dwyer
                                  ---------------------------
                                  Name:  Stephen F. Dwyer
                                  Title:    Director

                              EMPLOYEE

                              /s/Collin D'Silva
                              ---------------------------
                              Name: Collin D'Silva

7

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00003-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00003-of-00352.parquet"}]]